Publication:
A Nested Case-Control Study of Metabolically Defined Body Size Phenotypes and Risk of Colorectal Cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC).

Loading...
Thumbnail Image

Date

2016-04-05

Authors

Murphy, Neil
Cross, Amanda J
Abubakar, Mustapha
Jenab, Mazda
Aleksandrova, Krasimira
Boutron-Ruault, Marie-Christine
Dossus, Laure
Racine, Antoine
Kühn, Tilman
Katzke, Verena A

Advisors

Journal Title

Journal ISSN

Volume Title

Publisher

Metrics
Google Scholar
Export

Research Projects

Organizational Units

Journal Issue

Abstract

Obesity is positively associated with colorectal cancer. Recently, body size subtypes categorised by the prevalence of hyperinsulinaemia have been defined, and metabolically healthy overweight/obese individuals (without hyperinsulinaemia) have been suggested to be at lower risk of cardiovascular disease than their metabolically unhealthy (hyperinsulinaemic) overweight/obese counterparts. Whether similarly variable relationships exist for metabolically defined body size phenotypes and colorectal cancer risk is unknown. The association of metabolically defined body size phenotypes with colorectal cancer was investigated in a case-control study nested within the European Prospective Investigation into Cancer and Nutrition (EPIC) study. Metabolic health/body size phenotypes were defined according to hyperinsulinaemia status using serum concentrations of C-peptide, a marker of insulin secretion. A total of 737 incident colorectal cancer cases and 737 matched controls were divided into tertiles based on the distribution of C-peptide concentration amongst the control population, and participants were classified as metabolically healthy if below the first tertile of C-peptide and metabolically unhealthy if above the first tertile. These metabolic health definitions were then combined with body mass index (BMI) measurements to create four metabolic health/body size phenotype categories: (1) metabolically healthy/normal weight (BMI These results support the idea that individuals with the metabolically healthy/overweight phenotype (with normal insulin levels) are at lower colorectal cancer risk than those with hyperinsulinaemia. The combination of anthropometric measures with metabolic parameters, such as C-peptide, may be useful for defining strata of the population at greater risk of colorectal cancer.

Description

MeSH Terms

Adiposity
Biomarkers
Body Mass Index
Body Size
C-Peptide
Case-Control Studies
Chi-Square Distribution
Colorectal Neoplasms
Europe
Female
Health Status
Humans
Hyperinsulinism
Incidence
Logistic Models
Male
Middle Aged
Multivariate Analysis
Obesity
Obesity, Metabolically Benign
Odds Ratio
Phenotype
Prospective Studies
Protective Factors
Risk Assessment
Risk Factors
Waist Circumference

DeCS Terms

CIE Terms

Keywords

Citation